Table 1 Patient characteristics
All patients | Basal-like | HER2+/ER- | Luminal B | Luminal B(HER2+) | Luminal A | |
|---|---|---|---|---|---|---|
N (%) | 143 | 40 | 30 | 32 | 32 | 9 |
Median age (range) | 50 (27,73) | 50 (28,70) | 54 (36,73) | 49 (27,61) | 47 (32,68) | 47 (35,64) |
T1 | 36 | 11 | 8 | 7 | 10 | 0 |
T2 | 91 | 24 | 20 | 22 | 19 | 6 |
T3 | 16 | 5 | 2 | 3 | 3 | 3 |
Stage II | 109 | 36 | 21 | 20 | 25 | 7 |
Stage III | 34 | 4 | 9 | 12 | 7 | 2 |
Premenopause | 77 | 20 | 13 | 17 | 22 | 5 |
Postmenopausal | 66 | 20 | 17 | 15 | 10 | 4 |
Chemotherapy successful cases | 132 | 35 | 30 | 28 | 30 | 9 |
Chemotherapy failure case | 11 | 5 | 0 | 4 | 2 | 0 |